← back to search

Zerui Zhang

Huazhong University of Science and Technology · CN
Area of research
Oncology · Molecular Biology
Research interest
Research topics from publications: Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapy; SOX on tumors, a comfort or a constraint?; Various interventions for cancer-related fatigue in patients with breast cancer: a systematic review and network meta-analysis. Representative work: Transcription factor BTB domain and CNC homology 1 (BACH1) belongs to the Cap 'n' Collar and basic region Leucine Zipper (CNC-bZIP) family. BACH1 is widely expressed in mammalian tissues, where it regulates epigenetic modifications, heme homeostasis, and oxidative stress. Additionally, it is involved in immune system development. More importantly, BACH1 is highly expressed in and plays a key role in numerous malignant tumors, affecting cellular metabolism, tumor invasion and metastasis, proliferation, different cell death pathways, drug resistance, and the tumor microenvironment. However, few articles systematically summarized the roles of BACH1 in cancer. This review aims to highlight the r The sex-determining region Y (SRY)-related high-mobility group (HMG) box (SOX) family, composed of 20 transcription factors, is a conserved family with a highly homologous HMG domain. Due to their crucial role in determining cell fate, the dysregulation of SOX family members is closely associated with tumorigenesis, including tumor invasion, metastasis, proliferation, apoptosis, epithelial-mesenchymal transition, stemness and drug resistance. Despite considerable research to investigate the mechanisms and functions of the SOX family, confusion remains regarding aspects such as the role of the SOX family in tumor immune microenvironment (TIME) and contradictory impacts the SOX family exerts o
h-index
citations
0
works
0
NIH funding
primary concept
email

Recent publications

Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapy
Biomarker Research 2024cited by 33position: middledoi
SOX on tumors, a comfort or a constraint?
Cell Death Discovery 2024cited by 25position: middledoi
Various interventions for cancer-related fatigue in patients with breast cancer: a systematic review and network meta-analysis
Frontiers in Oncology 2024cited by 6position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiangyuan Luo · Huazhong University of Science and Technology2 papers (2024–2024)Zhangfan Wu · Huazhong University of Science and Technology2 papers (2024–2024)Junqing Jiang · Tianjin University of Traditional Chinese Medicine2 papers (2024–2024)Dian Hu · Huazhong University of Science and Technology2 papers (2024–2024)Mengyu Sun · Huazhong University of Science and Technology2 papers (2024–2024)Limin Xia · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2024–2024)Shengjun Xu · Zhejiang University2 papers (2024–2024)Wenjie Huang · Guangxi Academy of Agricultural Science2 papers (2024–2024)Jiaqian Zhang · Ningbo University2 papers (2024–2024)Bixiang Zhang · Wuhan Institute of Technology2 papers (2024–2024)Xiaoping Chen · Ministry of Education of the People's Republic of China2 papers (2024–2024)Siwen Li · Zhujiang Hospital2 papers (2024–2024)Yaqing Chao · Xuzhou Medical College1 papers (2024–2024)Xiao Xu · Shenzhen University1 papers (2024–2024)Jing Lian · Guangxi University1 papers (2024–2024)Yijun Wang · Union Hospital1 papers (2024–2024)Xiao Xu · Huashan Hospital1 papers (2024–2024)Xiaoan Chen · Chongqing University1 papers (2024–2024)Ruoqi Li · Shanxi Medical University1 papers (2024–2024)Shu‐Ming Li · Shanxi Medical University1 papers (2024–2024)